文献速递乳腺技术与安全US乳腺X线

SCOUT®雷达反射器用于乳腺及腋窝不可触及病灶定位:首批500例患者经验

SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients.
PubMed 文献 · Clin Radiol · 2024-12-12

这项前瞻性队列研究描述了首批500例(2020年7月23日至2022年4月4日)接受SCOUT®雷达反射器定位乳腺及腋窝病灶的临床经验。结果显示,424例(84.8%)植入单个装置,361例在超声引导下植入、128例在立体定向引导下植入、11例在乳腺X线与超声双引导下植入;33例成功用于淋巴结识别以行靶向腋窝清扫。作者认为SCOUT®是前景良好的术前定位装置,可能优化临床流程。

要点

  • SCOUT®雷达反射器可术前定位乳腺及腋窝不可触及病灶,424例(84.8%)植入单个装置。
  • 植入引导方式以超声为主(361例),其次为立体定向(128例)和双引导(11例)。
  • 33例成功将SCOUT®用于淋巴结识别,以行靶向腋窝清扫。

核心结论

  • 作者认为SCOUT®是前景良好的乳腺及腋窝不可触及病灶术前定位装置,可能通过省去传统定位标记的单独定位操作来优化临床流程。

研究设计与样本

  • 前瞻性队列研究,描述首批500例接受SCOUT®定位乳腺及腋窝病灶患者的临床经验,时间范围为2020年7月23日至2022年4月4日。
  • 研究指标包括患者人口学特征、病灶位置、诊断路径(筛查或症状性)、影像学、手术及病理结局。

关键影像表现/征象

  • 500例中424例(84.8%)植入单个装置。
  • 361例在超声引导下植入SCOUT®,128例在立体定向引导下植入,11例在乳腺X线与超声双引导下植入。
  • 33例成功植入SCOUT®用于淋巴结识别,以行靶向腋窝清扫。
  • SCOUT®植入与计划手术之间的平均时间为40.6天。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: This study aimed to detail our experience of using SCOUT® radar reflector for lesion localisation in the breast and axilla.

MATERIALS AND METHODS: This is a prospective cohort study describing our clinical experience with the first 500 patients who received SCOUT® to localise lesions in the breast and axilla (from 23 July 2020 to 4 April 2022). Study measures include patient demographics, lesion location, diagnostic pathways (screening or symptomatic), imaging, and surgical and pathology outcomes.

RESULTS: Of the 500 patients, most patients (n = 424; 84.8%) had a single device inserted. A total of 361 had SCOUT® inserted under ultrasound guidance, 128 under stereotactic guidance, and 11 under dual mammographic and ultrasonographic guidance. We successfully inserted SCOUT® in 33 patients for lymph node identification for potential targeted axillary dissection. The mean time between SCOUT® insertion and the planned surgical procedure was 40.6 days.

CONCLUSION: Our results suggest that SCOUT® is a promising preoperative localisation device for nonpalpable breast and axillary lesions. Its implementation has the potential to optimise the clinical workflow by eliminating the need for a separate localisation procedure using conventional localisation markers and streamlining the treatment pathway.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Siddiqui S, Povey M, Rowland M, et al. SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients. Clin Radiol. 2024. PMID: 39756252. doi:10.1016/j.crad.2024.106777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。